PTJ
AGIO icon

Paul Tudor Jones’s Agios Pharmaceuticals AGIO Stock Holding History

Paul Tudor Jones’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,700
Closed -$463K – 3481
2026
Q1 		$463K Buy
13,700
+2,000
+17% +$56.7K ﹤0.01% 2867
2025
Q4 		$318K Buy
+11,700
New +$410K ﹤0.01% 3007

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Paul Tudor Jones's AGIO Position: Q2 2026 in Review

Paul Tudor Jones increased its Agios Pharmaceuticals (AGIO) stake by 13% in Q2 2026, buying an estimated $231K and bringing the position to 65,779 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1800.

Paul Tudor Jones first reported a position in AGIO in Q4 2014 and has held it in 20 quarters since. The position peaked at $2.75M in Q4 2021. 236 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Paul Tudor Jones held 65,779 shares of Agios Pharmaceuticals worth $2.44M as of Q2 2026.
  • Paul Tudor Jones bought 7,628 Agios Pharmaceuticals shares in Q2 2026, an estimated $231K.
  • Agios Pharmaceuticals made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1800 holding.
  • Paul Tudor Jones first reported a position in Agios Pharmaceuticals in Q4 2014 and has held it in 20 quarters since.
  • Paul Tudor Jones's Agios Pharmaceuticals position peaked at $2.75M in Q4 2021.
  • 236 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.